Clinical Trial Update: Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for cadonilimab in locally advanced MSI-H/dMMR colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cadonilimab

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: dMMR Colorectal Cancer | Phase 2 | Status: UNKNOWN